Mesoblast
MESO
43 hedge funds and large institutions have $12.4M invested in Mesoblast in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 4 closing their positions.
430% more call options, than puts
Call options by funds: $6.75M | Put options by funds: $1.27M
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
27% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 11
23% more capital invested
Capital invested by funds: $10.1M → $12.4M (+$2.32M)
10% more funds holding
Funds holding: 39 → 43 (+4)
0.01% more ownership
Funds ownership: 0.13% → 0.14% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$611K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$299K |
| 3 |
XC
XY Capital
Central,
Hong Kong
|
+$203K |
| 4 |
Jane Street
New York
|
+$183K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$174K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$440K |
| 2 |
CIC
Chase Investment Counsel
Charlottesville,
Virginia
|
-$405K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$253K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$176K |
| 5 |
PM
Penbrook Management
New York
|
-$120K |
MESO Hedge Fund Activity: Q3 2024 in Review
43 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q3 2024, worth a combined $12.4M — up 23% from $10.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MESO positions and 4 closed out — a net gain of 5 holders — while 14 added to existing stakes and 11 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $611K. The largest seller was Marshall Wace, cutting an estimated $440K.
- 43 institutional investors held Mesoblast (MESO) as of Q3 2024, up from 39 in Q2 2024.
- Funds reported $12.4M of Mesoblast stock for Q3 2024, up 23% quarter-over-quarter.
- 9 funds opened new Mesoblast positions in Q3 2024 and 4 closed out, a net change of +5 holders.
- The largest Mesoblast buyer in Q3 2024 was Morgan Stanley, an estimated $611K added.
- The largest Mesoblast seller in Q3 2024 was Marshall Wace, an estimated $440K sold.
Based on aggregated 13F filings for Q3 2024.